Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04159948
Other study ID # CWIUH-CHO (16-2019)
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date January 20, 2020
Est. completion date August 10, 2021

Study information

Verified date July 2021
Source Coombe Women and Infants University Hospital
Contact Ruairi Irwin
Phone +353877497263
Email r.irwin1987@gmail.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Prior to caesarean section, patients should fast from solid food for 6 hours and from clear fluids for 2 hours. Carbohydrate drinks can also be consumed up to 2 hours before surgery. These drinks have been shown to improve patient well-being after surgery and may potentially improve the neonatal blood glucose level after delivery and reduce the risk of a low blood glucose level. This study aims to assess the influence of pre-operative carbohydrate drinks on blood glucose levels of the baby at delivery.


Description:

Patients recruited to the study will be randomised to one of 3 groups. Group 1 will receive standard care as per our current practice. This includes fasting from solids for 6 hours prior to surgery and clear fluids for up to 2 hours prior to surgery. Group 2 will receive a carbohydrate (CHO) drink preoperatively as well as adhering to standard care. Patients will be allowed to drink this CHO drink as required from admission to hospital on the morning of their surgery. They will also receive a further 400ml bolus at 2 hours prior to surgery. Group 3 will receive an apple juice drink preoperatively as well as adhering to standard care. Patients will be allowed to drink this apple juice drink as required from admission to hospital on the morning of their surgery. They will also receive a further 400ml bolus at 2 hours prior to surgery. Before the start of surgery, the patients non-dominant hand grip strength will be assessed using the dynamometer. Their subjective sense of thirst and hunger will be assessed. Their fasting times for food and fluids will be recorded. The patients' blood glucose will be measured from a blood sample as their intravenous cannula is inserted. The maternal urinary ketones will be measured from a urine sample upon insertion. The neonatal blood cord glucose will be measured from both an arterial and venous cord blood sample after delivery. This will be performed by the trained anaesthesia research fellow. Should hypoglycemia be identified, the hospital's neonatal hypoglycemia algorithm will be followed appropriately. The patients will be followed up at 24 hours by an outcome assessor blinded to the group allocation. Numerical rating scale (NRS) pain scores, postoperative nausea and vomiting and quality of recovery will be assessed at the patients beside. All neonates will be followed up to calculate admissions to neonatal unit and the number of glucose sachets required for hypoglycemia.


Recruitment information / eligibility

Status Recruiting
Enrollment 69
Est. completion date August 10, 2021
Est. primary completion date August 10, 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years and older
Eligibility Inclusion Criteria: - Elective caesarean section for singleton pregnancy under neuraxial anaesthesia. - Subjects able to give informed consent and willing to comply with the study protocol. - Subjects must be greater than 18 years old. Exclusion Criteria: - Diabetes Mellitus - including gestational diabetes. - Known foetal abnormality. - General anaesthesia. - Gestation < 37 weeks. - Steroids received within 4 days of delivery. - Low birth weight 2.5 kg (IUGR) - BMI > 40 kg/m2

Study Design


Intervention

Dietary Supplement:
Carbohydrate drink
This is a commercially available "pre-op" carbohydrate drink used in enhanced recovery programmes.

Locations

Country Name City State
Ireland Coombe Women and Infants University Hospital Dublin

Sponsors (1)

Lead Sponsor Collaborator
Coombe Women and Infants University Hospital

Country where clinical trial is conducted

Ireland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Neonatal cord blood glucose A blood sample of the neonatal cord will be checked immediately after delivery. 0 hours
Secondary Neonate tolerating 1st oral feeding. Binary outcome - Neonate consuming adequate breast or bottle milk. 0-2 hours
Secondary Number of neonatal rescue oral glucose sachets given. Continuous - Number of neonatal rescue oral glucose sachets given. 6 hours
Secondary Neonate requiring ICU admission and treatment for hypoglycemia Binary - Neonate requiring ICU admission and treatment for hypoglycemia 6 hours
Secondary Maternal blood glucose Maternal blood glucose prior to the start of caesarean section. 0 hours
Secondary Maternal urinary ketones Maternal urinary ketones prior to the start of caesarean section. 0 hours
Secondary Maternal subjective sense of thirst prior to the start of caesarean section. Scored on a scale 0-10 0 hours
Secondary Maternal subjective sense of hunger prior to the start of caesarean section. Scored on a scale 0-10 0 hours
Secondary Maternal quality of recovery Measured using the ObsQoR-11 questionnaire 24 hours
Secondary Resumption of oral diet post caesarean section. Time until resumption of oral diet 24 hours
Secondary Resumption of fluids post caesarean section. Time until resumption of fluids 24 hours
Secondary Post-operative nausea and vomiting (PONV) The self reported incidence of PONV 24 hours
Secondary PONV requiring treatment PONV requiring pharmacological treatment 24 hours
Secondary Pain scores Pain scores at rest and movement on scale 0-10 24 hours
Secondary Breastfeeding success Binary - whether continuing attempted breast feeding at 24 hours 24 hours
See also
  Status Clinical Trial Phase
Active, not recruiting NCT03754920 - Prolonged Fasting With Meditation and Mild Physical Exercise N/A
Completed NCT05272332 - Gastric Ultrasound Prior to Extubation
Completed NCT04247464 - Short-term Fasting as an Enhancer of Chemotherapy: Pilot Clinical Study on Colorectal Carcinoma Patients N/A
Completed NCT01067001 - Minocycline HCl Extended Release Tablets 135 mg Oral Bioequivalence Study N/A
Completed NCT00757094 - Safety and Feasibility of Fasting While Receiving Chemotherapy N/A
Completed NCT01506713 - Bioequivalence Study of Clopidogrel Tablets 75 mg of Dr. Reddy's Under Fasting Conditions Phase 1
Completed NCT04514380 - Effect of Drinking Carbohydrate-containing Fluids on Gastric Residual Volume in Elderly Patients
Completed NCT05756868 - The Effect of Time-Restricted Feeding on Anthropometry, Biochemical Parameters, Diet Quality and Eating Behavior N/A
Completed NCT05134207 - The Effect of Oral Carbohydrate Solution on Anxiety and Comfort in Patients Undergoing Hip Arthroplasty N/A
Completed NCT05031598 - Long-term Fasting: Multi-system Adaptations in Humans N/A
Recruiting NCT04501393 - Recommended Clear Fluid Intake Volume at 2 Hours Prior to Esophagogastroduodenoscopy for Adult Patients N/A
Enrolling by invitation NCT04027478 - Can Fasting Decrease the Side Effects of Chemotherapy? N/A
Completed NCT05219136 - Improve the Comfort, Safety and Quality of Upper Endoscopy by a Modified Fasting Protocol N/A
Recruiting NCT04625608 - Effect of Premedicant Oral Paracetamol on Gastric Volume and pH Phase 4
Not yet recruiting NCT02562638 - Pre-Procedural Fasting in Cardiac Intervention N/A
Completed NCT01949987 - Does Oral Intake Decreases Postoperative Pain Score in Children N/A
Completed NCT01954836 - Short-Term Fasting During Chemotherapy in Patients With Gynecological Cancer- a Randomized Controlled Cross-over Trial N/A
Completed NCT01713647 - Bioequivalence Study of Amlodipine / Losartan/ Hydrochlorothiazide of PHARMALINE, Lebanon Under Fastion Conditions Phase 1
Completed NCT01746719 - Bioequivalence Study of Etodolac Capsules USP 300 mg Under Fasting Condition Phase 1
Completed NCT01831700 - Bioequivalence Study of Lisinopril and Hydrochlorothiazide Tablets (20+25) mg Under Fasting Conditions Phase 1